Ten‐year prognosis in multiple sclerosis: a better outcome in relapsing−remitting patients but not in primary progressive patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|22|3|507-e35

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.22, Iss.3, 2015-03, pp. : 507-e35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of new application system in Portuguese patients with relapsing-remitting multiple sclerosis

By de Sá J.   Urbano G.   Reis L.  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2237-2242

Informa Healthcare

Access to resources Recommend Favorite

Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

By Robinson D.   Zhao N.   Gathany T.   Kim L.-L.   Cella D.   Revicki D.  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1121-1130

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing–remitting multiple sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 564-569

John Wiley & Sons Inc

Access to resources Recommend Favorite

PK and PD of peginterferon beta‐1a in multiple sclerosis patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 3, 2015-03 ,pp. : 514-522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

By  

Reviews on Recent Clinical Trials, Vol. 5, Iss. 3, 2010-09 ,pp. : 179-188

Bentham Science Publishers

Access to resources Recommend Favorite